MaxCyte, Inc. (MXCT) Social Stream
Maxcyte Inc (MXCT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MXCT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $22 | $18 | $19.667 | $6.9 | 185.03% |
| 2022-03-22 | 5 | $22 | $18 | $19.666 | $6.9 | 185.01% |
MXCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Maxcyte Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 173.09% of that group.
- To contextualize these metrics, consider that out of Business Services stocks, Maxcyte Inc's variance in analysts' estimates is lower than 71.36% of them.
- To contextualize these metrics, consider that out of Business Services stocks, Maxcyte Inc's average analyst price target is higher than 34.33% of them.
- To contextualize these metrics, consider that out of Business Services stocks, Maxcyte Inc's number of analysts covering the stock is higher than 38.06% of them.
In the Business Services industry, LUNA, ELOX, and AVXL are the three stocks most similar to Maxcyte Inc regarding the price target and analyst recommendation information presented here.
Is MXCT a Buy, Hold or Sell? See the POWR Ratings now!